K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.46 HKD 1.41% Market Closed
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Kangji Medical Holdings Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kangji Medical Holdings Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
K
Kangji Medical Holdings Ltd
HKEX:9997
Accounts Payable
ÂĄ34.1m
CAGR 3-Years
44%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Accounts Payable
ÂĄ4.7B
CAGR 3-Years
40%
CAGR 5-Years
37%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Accounts Payable
ÂĄ759m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
11%
Autobio Diagnostics Co Ltd
SSE:603658
Accounts Payable
ÂĄ462.6m
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Accounts Payable
ÂĄ1.1B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Accounts Payable
ÂĄ127m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.28 HKD
Undervaluation 37%
Intrinsic Value
Price
K

See Also

What is Kangji Medical Holdings Ltd's Accounts Payable?
Accounts Payable
34.1m CNY

Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Accounts Payable amounts to 34.1m CNY.

What is Kangji Medical Holdings Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
38%

Over the last year, the Accounts Payable growth was 65%. The average annual Accounts Payable growth rates for Kangji Medical Holdings Ltd have been 44% over the past three years , 38% over the past five years .

Back to Top